Skip to main content
logo
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.270
-0.140 (-4.11%)
At close: Aug 10, 2026, 4:00 PM EDT
3.340
+0.070 (2.14%)
After-hours: Aug 10, 2026, 7:18 PM EDT

HCW Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.590.052.572.846.72-
Revenue Growth
356.16%-97.89%-9.68%-57.73%--
Gross Profit
6.540.010.960.562.59-
Operating Income
-7.98-13.16-29.46-25.72-15.08-13.37
Net Income
-18.12-22.3-30.02-24.99-14.9-12.86
Earnings Per Share
-56.76-63.78-185.76-168.00-100.80-165.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.231.954.673.632.0636.71
Total Debt
6.586.8113.696.36.410
Net Cash (Debt)
-5.35-4.86-9.02-2.7125.6536.71
Net Cash Growth
-----30.13%334.19%
Net Cash Per Share
-9.99-13.89-55.79-18.10171.86469.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.45-13.39-14.23-22.51-10.39-10.98
Capital Expenditures
---0.26-6.2-10.28-0.05
Free Cash Flow
-11.45-13.39-14.49-28.72-20.66-11.02
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.24%20.00%37.38%19.72%38.48%-
Operating Margin
-121.09%-24270.70%-1147.60%-904.96%-224.32%-
Pretax Margin
57.68%-14677.14%-1169.70%-879.52%-221.67%-
Profit Margin
-34.74%-14677.10%-1169.70%-879.52%-221.67%-
FCF Margin
-173.74%-24693.20%-564.48%-1010.51%-307.36%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.6558.707.7415.5910.22-